Showing results (1-10 of 230) with videos related to
Sort By:
Pageof 23
Cerebellum (London, England)|April 18, 2008
Spinocerebellar ataxia 2 (SCA2)Isabel Lastres-Becker, Udo Rüb, Georg AuburgerNeurological Research and Practice|December 16, 2020
New alternative splicing variants of the ATXN2 transcriptIsabel Lastres-Becker, David Nonis, Joachim Nowock, et al.Biomolecules|May 27, 2023
Special Issue "Role of NRF2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches II"Isabel Lastres-BeckerBiomolecules|February 5, 2021
Special Issue "Role of NRF2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches"Isabel Lastres-BeckerBiochimica Et Biophysica Acta|June 1, 2016
Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K/mTOR and is induced by starvationIsabel Lastres-Becker, David Nonis, Florian Eich, et al.Human Molecular Genetics|February 6, 2008
Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out miceIsabel Lastres-Becker, Susanne Brodesser, Dieter Lütjohann, et al.Journal of Molecular Neuroscience : MN|January 22, 2013
Ataxin-2 modulates the levels of Grb2 and SRC but not ras signalingJessica Drost, David Nonis, Florian Eich, et al.Human Molecular Genetics|October 10, 2014
Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpressionSuzana Gispert, Nadine Brehm, Jonas Weil, et al.Plos Genetics|September 8, 2012
ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in miceEwa Damrath, Melanie V Heck, Suzana Gispert, et al.Current Medicinal Chemistry|December 16, 2006
An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatmentsIsabel Lastres-Becker, Javier Fernández-RuizPageof 23